✦ LIBER ✦

AOS12 Efficacy and safety of trabectedin versus gemcitabine/docetaxel in patients with sarcoma after failure of anthracycline and/or ifosfamide

✍ Scribed by K. Adam; M. Farid; A. Sairi; H. Widayana; A. Manaf; L. Soh; R. Quek

Book ID: 116431052
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 50 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.02.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II study of everolimus

Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide

✍ Yoo, Changhoon; Lee, Jeeyun; Rha, Sun Young; Park, Kyong Hwa; Kim, Tae Min; Kim, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 245 KB

7517 POSTER Clinical tolerability of tra

7517 POSTER Clinical tolerability of trabectedin administered by two different schedules (weekly for 3 of 4 weeks vs q3 weeks) in patients with advanced/metastatic liposarcoma or leiomyosarcoma (L-sarcomas) progressing despite prior treatment with at least anthracycline and ifosfamide

✍ Chawla, S.; Casali, P.G.; von Mehren, M.; Le Cesne, A.; Blay, J.Y.; Lebedinsky, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Efficacy and Safety of Regorafenib in Pa

Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial

✍ George, S.; Wang, Q.; Heinrich, M. C.; Corless, C. L.; Zhu, M.; Butrynski, J. E. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 248 KB

14 EFFICACY AND SAFETY OF WEIGHT-BASED R

14 EFFICACY AND SAFETY OF WEIGHT-BASED REGIMENS OF TARIBAVIRIN OR RIBAVIRIN, GIVEN WITH PEGINTERFERON ALFA-2B, AT 12 WEEKS AFTER TREATMENT (SVR12) IN NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC-HEPATITIS C

✍ F. Poordad; E. Lawitz; R. Pozza; M. Shiffman; B. Bacon; E. Godofsky; D. Halliman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase II open-label randomized study t

A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 640 KB

Erratum to: A phase II open-label random

Erratum to: A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 61 KB